亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Novel Antibody for Inhibiting Nodal-Dependent Activity

技术优势
High affinity to NodalHighly selectiveEasy to scale production
详细技术说明
Novel monoclonal antibody that inhibits the binding of Nodal to the Activin receptor complex #therapeutics #antibody #biomedical #researchtool
*Abstract

Northwestern researchers, together with Italian collaborators, have characterized a monoclonal antibody that inhibits the activity of Nodal, a growth factor driving abnormal growth in a variety of cancers. In normal development, Nodal is important in maintaining stem cell pluripotency, and subsequently disappears in most normal adult tissues. The inventors discovered, however, that Nodal is reactivated in aggressive tumor cells and is also associated with invasive disease states across many cancer types. Currently, existing technologies for inhibiting Nodal signaling are based on suppressing Nodal expression using antisense technology or commercial polyclonal antibodies, and there is no available Nodal-based ELISA. The novel monoclonal antibody described here is highly selective and possesses a high affinity to Nodal, and can be used effectively as a capture antibody in a sandwich-based ELISA. In addition, because it is easy to scale the production of this antibody, it is an ideal candidate for pharmaceutical development. 

*Inventors
Mary Hendrix*Elisabeth Seftor Richard SeftorMenotti Ruvo AnnaMaria SandomenicoAntonio LeonardiLuca SanguignoLuigi StrizziZhila Khalkhali-Ellis
*Publications
Topczewska JM, Postovit L-M, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J and Hendrix MJC (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Medicine, 12, 925-932. Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR, Lai J, APC BioResource, Postovit L-M, Clements JA, Hendrix MJC (2011). Reactivation of Embryonic Nodal Signaling is Associated with Tumor Progression and Promotes the Growth of Prostate Cancer Cells. Prostate, 71(11).
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备